• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NUZ

NEURIZON THERAPEUTICS LIMITED - News & Media

3.23% ! 16.0¢
Market Cap $78.76M  !
Healthcare Biotechnology
Add to My Watchlist

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight arrow Created with Sketch.

NUZ ADVANCES NUZ-001 & GLOBAL LICENSING AGREEMENT

Articles & Videos

Neurizon inks $1.5M loan against R&D Tax Rebate

Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...

30 Jul 2025 12:48 (AEST)

Neurizon significantly advances NUZ-001, enters global licensing agreement

Neurizon Therapeutics (ASX:NUZ) has this week arrived at its next @watershed moment” as it looks to become a leader in neurodegenerative disease treatments, executing a global license agreement with Elanco Animal Health Inc.Listen to the HotCopper podcast for in-depth discus...

04 Jul 2025 09:28 (AEST)

This stock is crafting a cure for Huntington's – and it's making progress

Neurizon Therapeutics (ASX:NUZ) has declared that its in-house product NUZ-001 Sulfone granted neuroprotective effects...

16 Jun 2025 13:36 (AEST)

Neurizon Therapeutics announces strong safety results in latest study

Drug candidate NUZ-001 has shown strong safety characteristics in its latest human 3D brain model study, Neurizon Therapeutics (ASX:NUZ) has confirmed this week.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify,...

14 Apr 2025 14:30 (AEST)

Neurizon finds positive results for lead drug in 3D brain model study

Neurizon Therapeutics Ltd has completed a study together with Tessara Therapeutics on the impact of NUZ-001 on a 3D model of the brain

01 Apr 2025 11:53 (AEDT)

'Maximising the potential': Neurizon prepares for HEALEY study of ALS

Neurizon Therapeutics Ltd has provided an update to its preparations for the HEALEY Platform Trial to assess products for ALS treatment

24 Mar 2025 12:05 (AEDT)

Neurizon snags US patent for NUZ-001 after winning FDA orphan status in 2024

Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, designated orphan status by the FDA last year. The microcap stock jumped +12% to 14cps in early trades, per Cboe live pricing data. The State-side move ultimately firms up ...

05 Feb 2025 10:45 (AEDT)

Neurizon's fast-track application for flagship drug in Europe received 'positively'

Neurizon's (ASX:NUZ) hopes have been lifted with a view towards winning fast-track status from a European health regulator.

11 Nov 2024 10:54 (AEDT)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
16.0¢ 		Change
0.005(3.23%) 		Mkt cap ! $78.76M
Open High Low Value Volume
16.0¢ 16.0¢ 16.0¢ $2.78K 17.37K

Buyers (Bids)

No. Vol. Price($)
6 430299 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 110106 6
View Market Depth
Last trade - 13.06pm 11/08/2025 (20 minute delay) ?
Last
15.5¢ 		  Change
0.005 ( 0.00 %)
Open High Low Volume
15.5¢ 16.0¢ 15.5¢ 91640
Last updated 14.42pm 11/08/2025 ?
NUZ (ASX) Chart

Top Stories

Can the market squeeze IDP Education's shorters? As of Week 33, it looks possible

IDP Education (ASX:IEL), a company that ultimately trains up foreign students moving to Australia, has long been one of the most...
The cash flow on demand strategy that works This week on Money and Investing, Mitch Olarenshaw and I break down the strategy behind Cash Flow on Demand @ a proven system for generating consistent income from the sharemarket with lower risk.1. The cash flow on demand strategyThis income strategy has been our flagship approach at Australian ...
Monday's HotCopper trends: DRO civ counterdrone, Dateline drill hits | Aug 11 DroneShield (ASX:DRO) has captured the most attention across the HotCopper forums through Week 33’s first trade day, sparking excitement with its new @SentryCiv,” a subscription-based AI counterdrone solution.Listen to the HotCopper podcast for in-depth discu...
DroneShield's civilian counter-drone tech lands with a buzz A silent guardian, standing tall and watching the skies. No, it’s not a superhero, but DroneShield’s (ASX:DRO) newest brainchild, SentryCiv: A new subscription-based counter-drone system for the civilian market.Listen to the HotCopper podcast for in-depth discussio...
Trump's not talking about Greenland – so why is ETM up +130%? Sixty Minutes is, in many ways, peak boomer. The not-so-shiny-anymore crown jewel of a media brand now more invested in property...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.